Alpha 2.0
Login Register
» Authors » Shahla Eyvari-Brooshghalan

Shahla Eyvari-Brooshghalan

Explore the profile of Shahla Eyvari-Brooshghalan including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 31
Followers 0
Related Specialties
Pharmacology
Neurology
Molecular Biology
Top 10 Co-Authors
Rasool Haddadi
Mohammadmahdi Sabahi
Alireza Mohajjel Nayebi
Alireza Komaki
Sara Ami Ahmadi
Siamak Shahidi
Masome Rashno
Ahmad Fadaiie
Abdolrahman Sarihi
Ali Kalantari
Published In
Naunyn Schmiedebergs Arch Pharmacol
Mol Neurobiol
Phytomedicine
Neurosci Lett
Affiliations
Soon will be listed here.
Recent Articles
1.
Acute Treatment with Fucoidan Ameliorates Traumatic Brain Injury-Induced Neurological Damages and Memory Deficits in Rats: Role of BBB Integrity, Microglial Activity, Neuroinflammation, and Oxidative Stress
Eyvari-Brooshghalan S, Haddadi R, Shahidi S, Ghaderi S, Rashno M, Kalantari A, et al.
Mol Neurobiol . 2024 Dec; PMID: 39692820
There is no acquiesced remedy for the treatment of traumatic brain injury (TBI)-associated impairment, especially cognitive decline. The first 24 h after TBI is a golden time for preventing the...
2.
Retraction Note: Neuronal degeneration and oxidative stress in the SNc of 6-OHDA intoxicated rats; improving role of silymarin long-term treatment
Haddadi R, Eyvari-Brooshghalan S, Nayebi A, Sabahi M, Ahmadi S
Naunyn Schmiedebergs Arch Pharmacol . 2023 Dec; 397(1):635. PMID: 38099938
No abstract available.
3.
Neuroprotective effects of silymarin in 3-nitropropionic acid-induced neurotoxicity in male mice: improving behavioral deficits by attenuating oxidative stress and neuroinflammation
Haddadi R, Eyvari-Brooshghalan S, Makhdoomi S, Fadaiie A, Komaki A, Daneshvar A
Naunyn Schmiedebergs Arch Pharmacol . 2023 Oct; 397(4):2447-2463. PMID: 37847410
3-Nitropropionic acid (3-NP) is strongly believed to be an irreversible inhibitor of mitochondrial complex II, leading to neural damage. This study aimed to investigate the neuroprotective effects of silymarin against...
4.
Post treatment with Gastrodin suppresses oxidative stress and attenuates motor disorders following 6-OHDA induced Parkinson disease
Sadeghian Z, Eyvari-Brooshghalan S, Sabahi M, Nourouzi N, Haddadi R
Neurosci Lett . 2022 Sep; 790:136884. PMID: 36162540
Background & Objective: Researchers are currently trying to find new therapies with better symptomatic activity and fewer side effects to manage Parkinson's disease (PD). Although the protective effect of pre-treatment...
5.
Silymarin and neurodegenerative diseases: Therapeutic potential and basic molecular mechanisms
Haddadi R, Shahidi Z, Eyvari-Brooshghalan S
Phytomedicine . 2020 Sep; 79:153320. PMID: 32920285
Background: Neurodegenerative diseases (NDDs) are primarily characterized by selective neuronal loss in the brain. Alzheimer's disease as the most common NDDs and the most prevalent cause of dementia is characterized...
6.
Neuronal degeneration and oxidative stress in the SNc of 6-OHDA intoxicated rats; improving role of silymarin long-term treatment
Haddadi R, Eyvari-Brooshghalan S, Nayebi A, Sabahi M, Ahmadi S
Naunyn Schmiedebergs Arch Pharmacol . 2020 Jul; 393(12):2427-2437. PMID: 32715318
Progressive loss in dopaminergic neurons (DA) of substantia nigra pars compacta (SNc) leads to Parkinson's disease with a hypothesis of oxidative stress generation. The present study was conducted to determine...